Related references
Note: Only part of the references are listed.The functional impact of 1,570 individual amino acid substitutions in human OTC
Russell S. Lo et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2023)
Barriers to a successful healthcare transition for individuals with urea cycle disorders
Farah A. Ladha et al.
MOLECULAR GENETICS AND METABOLISM (2023)
Effect of Ornithine Transcarbamylase (OTC) Deficiency on Pregnancy and Puerperium
Rastislav Sysak et al.
DIAGNOSTICS (2022)
Corticosteroid suppresses urea-cycle-related gene expressions in ornithine transcarbamylase deficiency
Koji Imoto et al.
BMC GASTROENTEROLOGY (2022)
Challenges of managing ornithine transcarbamylase deficiency in female heterozygotes
Annette Feigenbaum
Molecular Genetics and Metabolism Reports (2022)
Variable disease manifestations and metabolic management within a single family affected by ornithine transcarbamylase deficiency
Joshua Baker et al.
Molecular Genetics and Metabolism Reports (2022)
Benefits of tailored disease management in improving tremor, white matter hyperintensities, and liver enzymes in a child with heterozygous X-linked ornithine transcarbamylase deficiency
Ashley Andrews et al.
Molecular Genetics and Metabolism Reports (2022)
Liver transplantation in rare late-onset ornithine transcarbamylase deficiency with central nervous system injury: A case report and review of the literature
Xin Jin et al.
BRAIN AND BEHAVIOR (2022)
A complex case of delayed diagnosis of ornithine transcarbamylase deficiency in an adult patient with multiple comorbidities
Jessica Abbott et al.
Molecular Genetics and Metabolism Reports (2022)
Three-Country Snapshot of Ornithine Transcarbamylase Deficiency
Berna Seker Yilmaz et al.
LIFE-BASEL (2022)
Ornithine transcarbamylase deficiency and pregnancy: A case series and review of recommendations
Gabriella Pinho et al.
CASE REPORTS IN WOMENS HEALTH (2022)
Transition from paediatric to adult care: an emerging challenge
Shamali Abeyagunawardena et al.
Sri Lanka Journal of Child Health (2021)
Correction of a urea cycle defect after ex vivo gene editing of human hepatocytes
Mihaela Zabulica et al.
MOLECULAR THERAPY (2021)
Management of late onset urea cycle disorders-a remaining challenge for the intensivist?
S. Redant et al.
ANNALS OF INTENSIVE CARE (2021)
Challenges in Transition From Childhood to Adulthood Care in Rare Metabolic Diseases: Results From the First Multi-Center European Survey
Karolina M. Stepien et al.
FRONTIERS IN MEDICINE (2021)
Ornithine Transcarbamylase - From Structure to Metabolism: An Update
Morgane Couchet et al.
FRONTIERS IN PHYSIOLOGY (2021)
Adult-onset ornithine transcarbamylase deficiency as a rare cause of fatal hyperammonaemia
Seren Durer et al.
LANCET (2021)
Safety and efficacy of an engineered hepatotropic AAV gene therapy for ornithine transcarbamylase deficiency in cynomolgus monkeys
Julien Baruteau et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2021)
Valproate-induced fatal acute hyperammonaemia-related encephalopathy in late-onset ornithine transcarbamylase deficiency
Daniel Kazmierski et al.
BMJ CASE REPORTS (2021)
A mutation-independent CRISPR-Cas9-mediated gene targeting approach to treat a murine model of ornithine transcarbamylase deficiency
Lili Wang et al.
SCIENCE ADVANCES (2020)
Ammonia and coma - a case report of late onset hemizygous ornithine carbamyltransferase deficiency in 68-year-old female
Justus Marquetand et al.
BMC NEUROLOGY (2020)
Late-Onset Ornithine Transcarbamylase Deficiency and Variable Phenotypes in Vietnamese Females WithOTCMutations
Huy-Hoang Nguyen et al.
FRONTIERS IN PEDIATRICS (2020)
Clouds over IMD? Perspectives for inherited metabolic diseases in adults from a retrospective cohort study in two Swiss adult metabolic clinics
Karim Gariani et al.
ORPHANET JOURNAL OF RARE DISEASES (2020)
Clinical and molecular characteristics of 69 Chinese patients with ornithine transcarbamylase deficiency
Deyun Lu et al.
ORPHANET JOURNAL OF RARE DISEASES (2020)
Late-onset ornithine transcarbamylase deficiency: a rare cause of recurrent abnormal behavior in adults
Masaoki Hidaka et al.
ACUTE MEDICINE & SURGERY (2020)
Efficient in vivo editing of OTC-deficient patient-derived primary human hepatocytes
Samantha L. Ginn et al.
JHEP REPORTS (2020)
Suggested guidelines for the diagnosis and management of urea cycle disorders: First revision
Johannes Haberle et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2019)
Challenges in diagnosing and managing adult patients with urea cycle disorders
Karolina M. Stepien et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2019)
A New Era for Rare Genetic Diseases: Messenger RNA Therapy
Paolo G. Martini et al.
HUMAN GENE THERAPY (2019)
Progress and challenges in development of new therapies for urea cycle disorders
Leandro R. Soria et al.
HUMAN MOLECULAR GENETICS (2019)
Maternal ornithine transcarbamylase deficiency, a genetic condition associated with high maternal and neonatal mortality every clinician should know: A systematic review
Mehnoosh Torkzaban et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2019)
Transitions Clinical Report Authoring Group; American Academy of Pediatrics; American Academy of Family Physicians; American College of Physicians. Supporting the Health Care Transition From Adolescence to Adulthood in the Medical Home (vol 142, e20182587, 2018)
P. H. White et al.
PEDIATRICS (2019)
Adult Presentation of Ornithine Transcarbamylase Deficiency: 2 Illustrative Cases of Phenotypic Variability and Literature Review
Michael A. Pizzi et al.
NEUROHOSPITALIST (2019)
Human heterologous liver cells transiently improve hyperammonemia and ureagenesis in individuals with severe urea cycle disorders
Jochen Meyburg et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2018)
Human hepatocyte transplantation for liver disease: current status and future perspectives
V. Iansante et al.
PEDIATRIC RESEARCH (2018)
Transition from pediatric to adult care in adolescents with hereditary metabolic diseases: Specific guidelines from the French network for rare inherited metabolic diseases (G2M)
B. Chabrol et al.
ARCHIVES DE PEDIATRIE (2018)
Disease-causing mutations in the promoter and enhancer of the ornithine transcarbamylase gene
Yoon J. Jang et al.
HUMAN MUTATION (2018)
Prenatal treatment of ornithine transcarbamylase deficiency
Yael Wilnai et al.
MOLECULAR GENETICS AND METABOLISM (2018)
Targeted mRNA Therapy for Ornithine Transcarbamylase Deficiency
Mary G. Prieve et al.
MOLECULAR THERAPY (2018)
Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects
Julien Baruteau et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2017)
AAV gene therapy corrects OTC deficiency and prevents liver fibrosis in aged OTC-knock out heterozygous mice
Lili Wang et al.
MOLECULAR GENETICS AND METABOLISM (2017)
Urea Cycle Disorders in Neonates: Six Case Reports
Kiymet Celik et al.
JOURNAL OF PEDIATRIC RESEARCH (2017)
Neonatal mortality and outcome at the end of the first year of life in early onset urea cycle disorders-review and meta-analysis of observational studies published over more than 35 years
Peter Burgard et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2016)
A rare cause of postpartum coma: isolated hyperammonemia due to urea cycle disorder
Ayca Acikalin
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2016)
A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice
Yang Yang et al.
NATURE BIOTECHNOLOGY (2016)
Genotype-Phenotype Correlations in Ornithine Transcarbamylase Deficiency: A Mutation Update
Ljubica Caldovic et al.
JOURNAL OF GENETICS AND GENOMICS (2015)
Clinical outcomes and the mutation spectrum of the OTC gene in patients with ornithine transcarbamylase deficiency
Jin-Ho Choi et al.
JOURNAL OF HUMAN GENETICS (2015)
Initial presentation of a urea cycle disorder in adulthood: an under-recognised cause of severe neurological dysfunction
James R. Anstey et al.
MEDICAL JOURNAL OF AUSTRALIA (2015)
Long-term outcomes in Ornithine Transcarbamylase deficiency: a series of 90 patients
Anais Brassier et al.
ORPHANET JOURNAL OF RARE DISEASES (2015)
Early intervention for late-onset ornithine transcarbamylase deficiency
Daisuke Fujisawa et al.
PEDIATRICS INTERNATIONAL (2015)
Cross-sectional observational study of 208 patients with non-classical urea cycle disorders
Corinne M. Rueegger et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2014)
Investigating neurological deficits in carriers and affected patients with ornithine transcarbamylase deficiency
Courtney Sprouse et al.
MOLECULAR GENETICS AND METABOLISM (2014)
Selection and evaluation of clinically relevant AAV variants in a xenograft liver model
Leszek Lisowski et al.
NATURE (2014)
Sudden unexpected fatal encephalopathy in adults with OTC gene mutations-Clues for early diagnosis and timely treatment
Catia Cavicchi et al.
ORPHANET JOURNAL OF RARE DISEASES (2014)
Management of Ornithine Transcarbamylase Deficiency in Pregnancy
Hector Mendez-Figueroa et al.
AMERICAN JOURNAL OF PERINATOLOGY (2010)
Adult-onset ornithine transcarbamylase (OTC) deficiency unmasked by the Atkins' diet
Ziv Ben-Ari et al.
JOURNAL OF HEPATOLOGY (2010)
Fatal ammonia toxicity in an adult due to an undiagnosed urea cycle defect: under-recognition of ornithine transcarbamylase deficiency
Vanessa R. Thurlow et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2010)
Preimplantation genetic diagnosis for ornithine transcarbamylase deficiency by simultaneous analysis of duplex-nested PCR and fluorescence in situ hybridization : A case report
Hyoung-Song Lee et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2007)
Long-term correction of ammonia metabolism and prolonged survival in ornithine transcarbamylase-deficient mice following liver-directed treatment with adeno-associated viral vectors
David Moscioni et al.
MOLECULAR THERAPY (2006)
Current role of liver transplantation for the treatment of urea cycle disorders: A review of the worldwide English literature and 13 cases at Kyoto University
D Morioka et al.
LIVER TRANSPLANTATION (2005)
Metabolic and neuropsychological phenotype in women heterozygous for ornithine transcarbamylase deficiency
K Gyato et al.
ANNALS OF NEUROLOGY (2004)
Fatal presentation of ornithine transcarbamylase deficiency in a 62-year-old man and family studies
T Rohininath et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2004)
Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer
SE Raper et al.
MOLECULAR GENETICS AND METABOLISM (2003)
Mutations and polymorphisms in the human ornithine transcarbamylase gene
M Tuchman et al.
HUMAN MUTATION (2002)
Ornithine carbamoyltransferase deficiency
JE Wraith
ARCHIVES OF DISEASE IN CHILDHOOD (2001)